Search

EHA response to the EU’s Pharma Revision

Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation. In April 2023, the European Commission published a proposed Directive and Regulation to replace the current, outdated legal framework.

Read more

Genetic Predisposition to Blood Cancer (Rare diseases)

The objectives of the group are:

Share and extend clinical knowledge on the diagnosis and treatment of hematologic malignancies with germline predisposition.

Read more

Press Release "Crucial Directives must be revised to protect patients' interests and improve access to treatment"

This was a key message of a two-day conference, “Haematology and the next European decade”, hosted by the European Parliament and attended by doctors, researchers, parliamentarians, patients’ organisations and Commission officials.

Read more

Registration & accommodation

Registration is closed

Individual RegistrationHybrid registration fee includes:

Access to the scientific and educational sessions of the meeting
Networking opportunities to speak with the faculty during breaks and the welcome reception
Coffee/tea breaks on November 2-4 and lunches on November 3 and 4
Access to…

Read more

Abstract & Case Report submission

Late-breaking case report submission is now closed.

Read more

General Information

June 5, 2025
EHA2025 Congress platform opens

June 12-15, 2025
EHA2025 Milan, Italy - In-person and live stream

Location 
Allianz MiCo, Milano Convention Centre

August 15, 2025
EHA2025 Congress platform closes

 
 

Scientific Program Committee (SPC) Chair
Prof.

Read more

SWG Educational Activities

EHA2023 Hybrid CongressDate and locationJune 8–11, 2023, in Frankfurt, Germany. ChairMarie Jose Kersten

Case discussions
Follicular Lymphoma: Martin Dreylng, Daphne De Jong. Double hit Lymphoma: Andrew Davies, Elias Campo. T-follicular helper cell lymphoma: Andrew Davies, Daphne De Jong.

Read more

Travel Grants

Travel grant application is now closed. Travel grants are intended to support young investigators to participate in the 7th European CAR T-cell Meeting; therefore, applicants should be 40 years of age or younger.

Read more